CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Lasa Supergenerics Ltd

Lasa Supergenerics Ltd

BSE 540702 LASA INE670X01014
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 30 trading days

4 filings · 2 material · busiest 2026-08-14

What it files

KMP1 Board Outcome1 General1 Board Meeting1

Filings

4 in the window

  1. 25 August 2026

    KMP

    Cessation

    Resignation of Mr. Ganesh Potdar executive director as on 25-08-2026

    Company Update / Cessation View filing →

  2. 14 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended June 30, 2026

    Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....

    Board Meeting / Outcome of Board Meeting View filing →

  3. 14 August 2026

    General

    Integrated Filing For Quarter Ended June 30, 2026

    Integrated filing for Quarter ended June 30, 2026

    Company Update / General View filing →

  4. 4 August 2026

    Board Meeting

    Board Meeting Intimation for The Quarter Ended June 30,2026

    Lasa Supergenerics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

    Board Meeting / Board Meeting View filing →